← All Biofrontera INC filings

Biofrontera INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
BFRI
Biofrontera INC
SCHEDULE: Biofrontera AG Converts Preferred Stock, Boosts Stake
Biofrontera AG has converted Series D Preferred Stock into common shares of Biofrontera Inc., increasing its beneficial ownership to 19.54% and securing board representation rights.
NASDAQ
BFRI
Biofrontera INC
SCHEDULE: Biofrontera AG Updates Stake in Biofrontera Inc. with New Licensing Deal and Preferred Stock Issuance
Biofrontera AG and related entities updated their beneficial ownership in Biofrontera Inc. following a new agreement for U.S. rights to Ameluz and RhodoLED, involving a royalty structure and the issuance of convertible preferred stock.